Cleo Diagnostics (ASX:COV) Selling and Marketing Expense : A$ Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Cleo Diagnostics's Selling and Marketing Expense for the six months ended in Dec. 2023 was A$0.13 Mil. Cleo Diagnostics does not have enough years/quarters to calculate the Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023.

Cleo Diagnostics Selling and Marketing Expense Historical Data

The historical data trend for Cleo Diagnostics's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Selling and Marketing Expense Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Selling and Marketing Expense

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Selling and Marketing Expense	-	-	0.13

Cleo Diagnostics Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Cleo Diagnostics Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Selling and Marketing Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines